| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9155428 | American Heart Journal | 2005 | 7 Pages |
Abstract
If high-dose GIK significantly reduces mortality at 30 days in all patients, the adjunction of this treatment to reperfusion therapy may become part of standard regimen for patients with acute MI without heart failure.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Iwan C.C. MD, Jorik R. MD, Jan Paul MD, PhD, Henk J.G. MD, PhD, Rijk O.B. MD, PhD, Menko-Jan MD, PhD, Felix MD, PhD, on behalf of the GIPS Investigators on behalf of the GIPS Investigators,